The Diagnosis and Treatment of Primary CNS Lymphoma.
CONCLUSION: Current recommendations for the treatment of primary CNS lymphomaare based on only a small number of prospective clinical trials. Patients with this disease should be treated by interdisciplinary teams in experienced centers, andpreferably as part of a controlled trial.
PMID: 29999484 [PubMed - in process]
Source: Deutsches Arzteblatt International - Category: General Medicine Tags: Dtsch Arztebl Int Source Type: research
More News: Brain | Chemotherapy | Clinical Trials | Eyes | General Medicine | Lymphoma | Methotrexate | Neurology | Primary CNS Lymphoma | Rituxan | Stem Cell Therapy | Stem Cells | Toxicology | Transplants